Cyanoacrylate Versus Omentum for Staple-Line Reinforcement in Sleeve Gastrectomy
NCT ID: NCT07339020
Last Updated: 2026-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
100 participants
INTERVENTIONAL
2025-06-20
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Comparing Surgical Glue (Cyanoacrylate) vs. Omentum Tissue to Strengthen Staple Lines in Weight-Loss Sleeve Surgery
What is the purpose of this study? This study will compare two ways to strengthen the staple line during weight-loss sleeve surgery. One way uses a medical glue called cyanoacrylate, and the other uses a piece of tissue from the abdomen called omentum. The goal is to see which method works better to lower the chance of bleeding, pain, or leaks after surgery.
Who can take part?
Adults ages 18-65 who:
* Have a body mass index (BMI) over 35, or over 30 if they also have health problems related to obesity.
* Are scheduled to have weight-loss sleeve surgery at Cairo University Hospital.
Participants cannot take part if they:
* Are younger than 18 or older than 65.
* Have had weight-loss surgery before.
What will happen in the study?
* Participants will be assigned by chance to one of two groups:
1. Glue group: The staple line will be sealed with medical glue.
2. Omentum group:The staple line will be covered and sewn with a piece of the body's own tissue.
* Everyone will have the same type of surgery and be cared for in the same way afterward.
* Participants will be monitored closely for one month after surgery to check for problems like bleeding, pain, or leaks.
* Follow-up visits will happen within one week after surgery and again at one month.
What are the possible risks? The risks are low and similar to those of regular weight-loss surgery. Some people may feel pain or anxiety after surgery. The study team will watch for any problems and treat them right away.
Why is this study being done? Weight-loss sleeve surgery is common, but sometimes the staple line can leak or bleed. Finding a better way to strengthen it may help people recover more safely and with less pain.
How long will the study last? The study will take about six months to complete, including surgery and follow-up.
Who is running the study? The study is being done by doctors in the General Surgery Department at Cairo University's Faculty of Medicine.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Omentopexy With Glubran®2 for Reducing Complications After Sleeve Gastrectomy
NCT03833232
Efficacy of Oversewing Versus Surgical Ligation Clips for Staple Line Reinforcement of the Gastric Pouch to Reduce Post Operative Bleeding in Laparoscopic One Anastomosis Gastric Bypass
NCT07238309
Novel Technique in Closure of Mesenteric Defects After Laparoscopic Roux-en-Y Gastric Bypass and Its Effect on Internal Hernia: a Case-control Study
NCT04788199
Comparison of Omentopexy and Clips on the Staple Line During Laparoscopic Sleeve Gastrectomy
NCT06219668
Comparison of Staple Line Suturing in Laparoscopic Sleeve Gastrectomy
NCT04323696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: cyanoacrylate sealant (Glubran®)
Group A: the reinforcement of staple line was done by cyanoacrylate sealant (Glubran®) from the angle of His till the lower end using its applicator through the right working port
Glubran® 2 surgical glue (n-butyl-2-cyanoacrylate mixture) and its specific applicator.
A synthetic surgical adhesive applied to the staple line for reinforcement and hemostasis using its proprietary delivery applicator.
Staple Line Reinforcement during Laparoscopic Sleeve Gastrectomy
Reinforcement of the gastric staple line during laparoscopic sleeve gastrectomy.
Group B: Omentopexy
Group B: the reinforcement was done by suturing the greater omentum to the staple line using PDS 2/0 round.
Autologous Greater Omentum
pedicled flap of the patient's own greater omentum sutured over the staple line for reinforcement using a PDS 2/0 round needle suture.
Staple Line Reinforcement during Laparoscopic Sleeve Gastrectomy
Reinforcement of the gastric staple line during laparoscopic sleeve gastrectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glubran® 2 surgical glue (n-butyl-2-cyanoacrylate mixture) and its specific applicator.
A synthetic surgical adhesive applied to the staple line for reinforcement and hemostasis using its proprietary delivery applicator.
Autologous Greater Omentum
pedicled flap of the patient's own greater omentum sutured over the staple line for reinforcement using a PDS 2/0 round needle suture.
Staple Line Reinforcement during Laparoscopic Sleeve Gastrectomy
Reinforcement of the gastric staple line during laparoscopic sleeve gastrectomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Candidate for Laparoscopic Sleeve Gastrectomy
Exclusion Criteria
* Multiple Extensive previous surgeries.
* Crohn's Disease.
* Elderly patients with extensive comorbidities
* Severe gastroesophageal reflux disease (GERD)
* Severe Bleeding disorders
* Psychiatric illness or cognitive impairment affecting consent or compliance
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Eid Ali Ahmed Aziz
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Cairo University
Cairo, Al-Manial Cairo, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ms-199-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.